Ayşe Nur Hananel, who joined the Pfizer Türkiye family as an Executive Candidate (MT) in the New Product Development Department in 2003, became Ayşe Nur Hananel, Pfizer Türkiye Vaccines Business Unit Director (Category Lead).
After graduating from Boğaziçi University, Department of Business Administration in 2003, Ayşe Nur Hananel joined Pfizer Türkiye as a Manager Candidate (MT) in the New Product Development Department in the same year. Appointed as Product Manager in 2005 and working in Germany and England as European Product Manager between 2006-2008, Ayşe Nur Hananel became Senior Product Manager in 2008, Business Development Project Leader in 2010, and Business Development in 2011. Appointed as the Rare Diseases Europe Emerging Markets Regional Therapeutic Field Leader in 2013, Ayşe Nur Hananel served as the Middle East & Europe Region Rare Diseases Senior Marketing Director between 2015-2018. In addition to her responsibilities since 2017, Hananel took on the role of Business Unit Leader for the Rare Diseases Caucasus and Central Asia Region, and served as the Rare Diseases Business Unit Leader in Türkiye from 2018 to March 2023.
Ayşe Nur Hananel, Pfizer Türkiye Vaccines Business Unit Director (Category Lead), said the following about her new role, “Pfizer Türkiye, which has been delivering innovative drugs and vaccines to patients since 1957, is the local representative of global science and knowledge in Türkiye. Since 2012, we have been producing the conjugated pneumococcal vaccine, which is one of the most advanced technology products in the world and has one of the most challenging production processes, in Türkiye, starting from the formulation stage, within the scope of our cooperation with the domestic manufacturer Mefar. I am proud to be a member of Pfizer and the Vaccine Category Leader, working on breakthrough innovations that change patients’ lives with the understanding that science will win.”
